| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |